Imatinib Mesylate Tablet, Film Coated
Product Images NDC 72485-202

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Imatinib Mesylate (NDC 72485-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Fig1)

Image Description (Fig1)
This appears to be a figure related to a study or clinical trial, showing data on the progression-free survival of patients using two different treatments (Imatinib Mesylate and IFN+Arc-C). The figure includes a graph indicating the progression-free survival of the treatments over time, with the number of patients and hazard ratios also provided. The data is presented as months since randomization.*
FDA Label Image

Image Description (Fig2)

Image Description (Fig2)
This is a report of a study with results regarding the time taken for the progression of a disease. The graph in Figure 2 shows the percentage of patients without progression over time, and the numbers of patients with or without progression in each treatment group. The study involved imatinib mesylate and IFN+Arc-C treatments. The hazard ratio was 0.474 [95% CI: 0.312,0.722] with a statistically significant p-value (less than 0.001) based on the log-rank test. The time in months since randomization is shown on the x-axis.*
FDA Label Image

Image Description (Imatinib Struc1.1)

FDA Label Image

Image Description (Label1.3)

Image Description (Label1.3)
Each tablet contains 100mg of imatinib free base for the treatment of certain types of cancer. The usual dosage information is provided in the package insert. It is important to store the tablets in a light container at a temperature of 15-30°C (56-86°F) and keep them out of reach of children. The manufacturer is Shilpa Medicare Limited in India and the product is distributed by Mas Pharmaceutcl in the US. This is a prescription drug and the code is T?/DRUGS/013.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.